C18ORF32 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 9.31860000275009E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.02740000021917E-07 |
Normal-vs-Stage2 |
8.122300E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.413670E-02 |
Stage1-vs-Stage2 |
2.469600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.814000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
9.597400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.26870000247837E-08 |
Normal-vs-AfricanAmerican |
2.021400E-01 |
Normal-vs-Asian |
2.890800E-01 |
Caucasian-vs-AfricanAmerican |
8.506000E-01 |
Caucasian-vs-Asian |
3.547400E-01 |
AfricanAmerican-vs-Asian |
5.641200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.598520E-03 |
Normal-vs-Female |
1.41549999999047E-06 |
Male-vs-Female |
5.334800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.455410E-03 |
Normal-vs-Extreme_Weight |
1.014540E-04 |
Normal-vs-Obese |
3.603000E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.385900E-02 |
Normal_Weight-vs-Obese |
8.684200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.784200E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.26019999999272E-05 |
Normal-vs-Age(41-60Yrs) |
2.400000E-04 |
Normal-vs-Age(61-80Yrs) |
1.049270E-04 |
Normal-vs-Age(81-100Yrs) |
3.196600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.916200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.282200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.987800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.978400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.261610E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.226000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
3.951400E-01 |
Normal-vs-Grade 3 |
5.606400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
7.310400E-01 |
Grade 2-vs-Grade 4 |
3.951400E-01 |
Grade 3-vs-Grade 4 |
5.606400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.20859999996892E-06 |
Normal-vs-N1 |
8.588400E-02 |
N0-vs-N1 |
5.835600E-01 |
|
|